Jay Searles Email & Phone Number

Toronto, Ontario, Canada

Toronto, Ontario, Canada

Managing the launch of new biologic Adtralza (tralokinumab) and Patient Support Program within the University Health Network (UHN) Downtown Toronto. Engaging with key Dermatologists and Allergists to ensure patients have access to the latest treatment options for their disease.Develop and lead Key Account (KAM) strategy across brand portfolios

Toronto, Canada Area

• Responsible for promoting Entresto (sucubitril/valsartan) downtown Toronto to cardiology and electrophysiology key stakeholders in heart failure clinics and outpatient settings.
• Year-to-date (YTD) growth is 51% on 4-year product
• Territory sales at 102% vs 86% at the start of 2019 - highest since launch.
• Several projects initiated in key centres including optimization of therapy
• Achieved 100% formulary inclusion with positive protocols in place across all accounts

London, United Kingdom

• Market access and strategy management for new to market Oncology products. Working with the commissioning boards, medicines management and clinical commissioning groups as well as medical consultants, Clinical nurse.
• Ranked number one in the UK for year to date… Show more Market access and strategy management for new to market Oncology products. Working with the commissioning boards, medicines management and clinical commissioning.
• Ranked number one in the UK for year to date (YTD) sales
• Initiated the first UK NHS patient protocol and assisted with several department algorithms.
• Recognized globally for product growth and advocacy development.
• Presenting health improvement models to senior stakeholders in advanced renal cell carcinoma Show less

London, United Kingdom

• Promoted appropriate use of Simponi (golimumab) to key stakeholders in rheumatology, dermatology, and gastroenterology.
• Managed key teaching hospitals across London, delivering year-to-date (YTD) sales 101% versus target.
• Led cross-functional team on local health economy projects, promoting golimumab and creating advocacy champions for driving depth of prescribing.

London, United Kingdom

NHS Market Access and Strategy management. Working with the new NHS Commissioning boards, Medicines Management and Clinical Commissioning Groups.The role involved new product launch (dabigitran, Pradaxa), service development, driving audits, guideline development and both financial and capacity planning for new products pre license within the NHS. Health.

London, United Kingdom

Managing growth & development of key centres across London. Omalizumab (Xolair) - Monoclonal antibody therapy is the use of monoclonal antibodies (or mAb) to specifically bind to target cells or proteins. This may then stimulate the patient's immune system to attack those cells. It is possible to create a mAb specific to almost any extracellular/ cell.

London, United Kingdom

• Established territory of high-prescribing cardiovascular disease specialists in London key centres.
• Developed and prioritized business plans, including high-quality account plans for prioritized hospital trusts, maximizing uptake of new-to-market products across the territory.
• Completed successful product launch for the first DPP-4 inhibitor to market, using business analysis tools and matrix team leadership to target key influencers.
• Launched Januvia, Inergy (ezetimibe /… Show more Established territory of high-prescribing cardiovascular disease specialists in London key centres.
• Launched Januvia, Inergy (ezetimibe / simvastatin) and Etoricoxib into secondary care environment, which led to early use and advocacy development. Show less

Responsible for the maintenance and service of seaking helicopters Mk II-VI

Engineering C&G, Air Engineering Technology/ Electrical Engineering

Activities and Societies: Rugby, Tennis, Mountain biking, Advanced Education Programme

Marine Engineering Technology/ General Engineering

Bachelor Of Engineering - Be / Msc, Electrical And Electronics Engineering

Activities and Societies: Rugby, Tennis & Cycling teams